FDA.reportPublic FDA data

alyftrek 125 MG / 50 MG / 10 MG Oral Tablet

RxCUI
2701444
RxNorm name
alyftrek 125 MG / 50 MG / 10 MG Oral Tablet
Display name
alyftrek 125 MG / 50 MG / 10 MG Oral Tablet
Full name
alyftrek 125 MG / 50 MG / 10 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
7e635909-c6fd-4f0d-ae77-cdff03653a20alyftrek 125 MG / 50 MG / 10 MG Oral TabletPSN8These highlights do not include all the information needed to use ALYFTREK safely and effectively. See full prescribing information for ALYFTREK. ALYFTREK (vanzacaftor, tezacaftor, and deutivacaftor tablets), for oral use Initial U.S. Approval: 202420260323
7e635909-c6fd-4f0d-ae77-cdff03653a20deutivacaftor 125 MG / tezacaftor 50 MG / vanzacaftor 10 MG Oral Tablet [Alyftrek]SBD8These highlights do not include all the information needed to use ALYFTREK safely and effectively. See full prescribing information for ALYFTREK. ALYFTREK (vanzacaftor, tezacaftor, and deutivacaftor tablets), for oral use Initial U.S. Approval: 202420260323
7e635909-c6fd-4f0d-ae77-cdff03653a20Alyftrek 125 MG / 50 MG / 10 MG (equivalent to vanzacaftor calcium dihydrate 10.6 MG) Oral TabletSY8These highlights do not include all the information needed to use ALYFTREK safely and effectively. See full prescribing information for ALYFTREK. ALYFTREK (vanzacaftor, tezacaftor, and deutivacaftor tablets), for oral use Initial U.S. Approval: 202420260323